Bank of Montreal
ACRS icon

Bank of Montreal’s Aclaris Therapeutics ACRS Stock Holding History

Bank of Montreal’s Portfolio ACRS Stock Details ACRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-87,005
Closed -$1.57M – 3470
2021
Q3 		$1.57M Sell
87,005
-4,475
-5% -$71.7K ﹤0.01% 2216
2021
Q2 		$1.57M Buy
91,480
+26,098
+40% +$593K ﹤0.01% 2205
2021
Q1 		$1.9M Sell
65,382
-73,847
-53% -$1.44M ﹤0.01% 1824
2020
Q4 		$880K Buy
+139,229
New +$587K ﹤0.01% 2331
2020
Q1 		– Sell
-5,491
Closed -$10K – 4047
2019
Q4 		$10K Buy
5,491
+2,335
+74% +$3.87K ﹤0.01% 4560
2019
Q3 		$3K Buy
3,156
+74
+2% +$105 ﹤0.01% 4604
2019
Q2 		$7K Buy
3,082
+2,328
+309% +$12.7K ﹤0.01% 4613
2019
Q1 		$4K Sell
754
-207
-22% -$1.37K ﹤0.01% 4048
2018
Q4 		$7K Buy
961
+481
+100% +$4.96K ﹤0.01% 3970
2018
Q3 		$7K Sell
480
-7,464
-94% -$128K ﹤0.01% 4020
2018
Q2 		$159K Buy
7,944
+152
+2% +$2.81K ﹤0.01% 2878
2018
Q1 		$137K Buy
7,792
+7,415
+1,967% +$157K ﹤0.01% 2821
2017
Q4 		$9K Hold
377
– – ﹤0.01% 3796
2017
Q3 		$10K Sell
377
-6,760
-95% -$181K ﹤0.01% 3686
2017
Q2 		$194K Buy
7,137
+6,760
+1,793% +$184K ﹤0.01% 2666
2017
Q1 		$11K Hold
377
– – ﹤0.01% 3517
2016
Q4 		$11K Buy
+377
New +$9.61K ﹤0.01% 3552

Other funds holding ACRS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of Montreal's ACRS Position: Q4 2021 in Review

Bank of Montreal sold out of Aclaris Therapeutics (ACRS) in Q4 2021, closing a stake of 87,005 shares — an estimated $1.57M sold.

Bank of Montreal first reported a position in ACRS in Q4 2016 and held it in 17 quarters. The position peaked at $1.9M in Q1 2021. 133 funds tracked by Wall St. Rank hold ACRS as of Q4 2021.

  • Bank of Montreal reported no remaining Aclaris Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Bank of Montreal sold 87,005 Aclaris Therapeutics shares in Q4 2021, an estimated $1.57M.
  • Bank of Montreal first reported a position in Aclaris Therapeutics in Q4 2016 and held it in 17 quarters.
  • Bank of Montreal's Aclaris Therapeutics position peaked at $1.9M in Q1 2021.
  • 133 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.